Biocure Technology Inc. (BICTF)
OTCMKTS · Delayed Price · Currency is USD
0.0100
+0.0086 (614.29%)
At close: May 14, 2025
Biocure Technology Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
597.09K USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sorrento Therapeutics | 64.27M |
| SQZ Biotechnologies Company | 12.12M |
| EV Biologics | 9.47M |
| Regenerative Medical Technology Group | 5.04M |
| Helix BioMedix | 2.07M |
Biocure Technology News
- 1 year ago - CSE Bulletin: Consolidation - Biocure Technology Inc. (CURE.X) - Newsfile Corp
- 2 years ago - Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology - GlobeNewsWire
- 2 years ago - Biocure Technology Inc. Enters into Exclusive Letter Agreement to Acquire Atriva Therapeutics GmbH in Reverse Takeover Transaction - Newsfile Corp
- 4 years ago - Biocure Corporate Update - Newsfile Corp
- 4 years ago - Biocure Corporate Update and Financing - Newsfile Corp
- 4 years ago - Biocure Technology Inc. Announces Focus on its own CAR T-cell Therapy Targeting Chronic Lymphocytic Leukemia ("CLL") and Solid Tumor Cancers and Intent to Apply for Patents - Newsfile Corp
- 4 years ago - BioCure Technology Inc. Lists on the Frankfurt Stock Exchange and Completion of Issuer Sponsored Research Report - Newsfile Corp
- 4 years ago - BioCure Technology Inc. Announces New President, Appointment of Capital Markets Advisor and Grant of Stock Options - Newsfile Corp